Skip to content

Robert Scott Feferman, MD

NPI 1154479210ActiveIndividual· Specialist· Irving, TX

Specialist (MD) in Irving, Texas, licensed in TX, with an NPI issued in January 2007. Part D covered 2,316 prescriptions written in 2024, 76% of them generic. Abbvie Inc. was the largest of 19 companies reporting payments in 2025, $1,053 in all, mostly food and beverage.

Overview

NPI1154479210
StatusActive
Entity typeIndividual
CredentialMD
Sole proprietorYes
NPI issuedJan 8, 2007
Last updated in NPPESJan 3, 2017

Specialties and licenses

TaxonomyCodeLicenseState
Specialist Primary174400000XK4057TX

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Nov 10, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 11, 2026No match—
New York OMIG · Nov 11, 2026No match—
Ohio Medicaid · Nov 11, 2026No match—
Pennsylvania Medicheck · Nov 11, 2026No match—
Washington HCA · Nov 11, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Endocrinology (TX)

Part D prescriptions in 2024

Prescriptions (claims)2,316 · 4,292 30-day fills
Patients199
Total drug cost$309,382
Generic share76% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$1,053 · 64 payments from 19 companies
  • 2024$1,067 · 70 payments from 20 companies

Top paying companies in 2025

CompanyAmountPayments
Abbvie Inc.$262.7120
Novo Nordisk Inc$190.5913
Corcept Therapeutics$116.185
Amgen Inc.$73.583
Axsome Therapeutics, Inc.$68.403

What the 2025 payments were for

  • Food and Beverage$1,053 · 64 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Specialist providers in Irving

All Specialist providers in Texas →